Biotechs are typically highly focused on either products / assets or a technology platform, often with very few staff and significant outsourcing / partnering activity.

Typical Biotech Profile R&D spend of less than €10million per year. Spun out from University or pharma company. Privately funded by venture capital or publicly listed. Goal is to survive and move products to value inflexion point for exit sale or IPO.

Common Challenges      Manage liquidity-related pressures to cut costs and accelerate timelines. Manage scientific risks of novel and often unproven targets / technologies. Manage relationships with co-development and CRO partners. Fund drug development and commercialisation.

NovaSecta Engagement Scout and introduce investors, MidPharma, and Big Pharma partners. Conduct project / product valuations. Prepare business cases. Support negotiations with potential partners and investors.